Abstract
Amniotic membrane (AM) has been widely used as a temporary or permanent graft in the treatment of various ocular surface diseases. In this study, we compared the epithelial wound healing and tissue remodeling after ocular surface reconstruction with intact amniotic membrane (iAM) or denuded amniotic membrane (dAM). Partial limbal and bulbar conjunctival removal was performed on New Zealand rabbits followed by transplantation of cryo-preserved human iAM or dAM. In vivo observation showed that the epithelial ingrowth was faster on dAM compared to iAM after AM transplantation. Histological observation showed prominent epithelial stratification and increased goblet cell number on dAM after 2 weeks of follow up. Collagen VII degraded in dAM within 2 weeks, while remained in iAM even after 3 weeks. The number of macrophages and α-SMA positive cells in the stroma of remodelized conjunctiva in the dAM transplantation group was considerably less. In conclusion, dAM facilitates epithelial repopulation and goblet cell differentiation, further reduces inflammation and scar formation during conjunctival and corneal limbal reconstruction.
Similar content being viewed by others
Introduction
Amniotic membrane (AM), the innermost layer of the placental membrane, consists of a simple epithelium, a thick basement membrane, and an avascular stroma1,2. AM was first utilized as a dressing material in ocular surgery by Rotth and Sorsby in 19463,4, furthermore, Kim and Tseng in 1995 were the first to report the use of AM as graft5. Since then AM has been widely used for broad spectrum of ocular surface diseases. AM can be used both as a graft, sewn in place of corneal or conjunctival defect, or as a patch, sutured or glued against the ocular surface6, or sutureless amniotic membrane transplantation via ProKeraTM, a contact lens like instrument7. As a temporary patch, AM has been applied in the treatment of acute chemical/thermal burns8,9,10,11,12, acute inflammatory and ulcerative stage of Stevens–Johnson syndrome (SJS)13,14. As a permanent graft, it has been used in the treatment of corneal persistent epithelial defects and ulcers, neurotrophic keratitis15,16,17,18, bullous and band keratopathy19,20,21,22,23,24, primary and recurrent pterygia, chemical injury25, symblepharon26,27, and SJS28. Various studies have proved that AM exerts potent anti-inflammatory1,2,29,30,31,32, anti-scaring33,34, anti-angiogenic35, and promoting epithelial wound healing functions in the recipient eyes (for reviews, see2).
AM was also broadly used as a carrier either as intact amniotic membrane (iAM) or denuded amniotic membrane (dAM) to expand corneal36,37, conjunctival38,39, and oral mucosal epithelial cells40,41 for ocular surface reconstruction purpose. There are numerous studies compared the characteristics exhibited by corneal epithelial cells on iAM and dAM. Limbal epithelial cell suspension cultured on dAM showed better stratification and cell junction formation than that on iAM42. Limbal epithelial cells on iAM expressed ΔNp63α exhibiting the ability to maintain high proliferative potential, whereas cells cultured on dAM were ΔNp63α negative43. The limbal epithelial explant cultured over iAM expressed the stem cell associated markers (ABCG2, p63) and showed reduced expression of the differentiation markers (Connexin 43 and cytokeratin K3/K12) when compared to limbal epithelial cells cultured over dAM, therefore corneal epithelial cells maintain stemness better when cultured on iAM44. PI3K/Akt/FKHRL1 extracellular signal transduction pathway was observed to be activated when human limbal explants were cultured on iAM, but not on dAM45. Limbal explant cultured on dAM was not capable of maintaining the structural integrity of cultured epithelial cells46. Therefore, it is generally accepted that corneal limbal explant cultured on dAM showed higher outgrowth rate than that on iAM47,48, whereas limbal epithelial cells expanded on iAM maintained the progenitor phenotype efficiently than dAM. However, the underlying molecular mechanism that cause this difference is elusive.
Both iAM and dAM was utilized as efficient carrier in epithelial tissue engineering, but dAM has never been used as graft in ocular surface transplantation. The major perspective of amniotic membrane transplantation (AMT) is to reconstruct the ocular surface by enhancing re-epithelialization6. AMT has been successful in restoring the ocular surface, reducing scarring and inflammation in case of acute ocular burns, SJS, etc.49,50. AMT as a standalone therapy was an effective treatment for partial limbal stem cell deficiency, whereby AM was considered as an in vivo carrier for limbal epithelial cell expansion51. Since iAM and dAM showed significant difference during ex vivo expansion of epithelial cells, we proposed the hypothesis that the process of re-epithelialization and tissue remodeling may vary when the ocular surface is reconstructed with iAM or dAM. In this study, we tested this hypothesis using rabbit partial ocular surface reconstruction model. We observed that dAM facilitated epithelial repopulation, goblet cell differentiation, reduced inflammation and scar formation during ocular surface reconstruction. The efficacy of dAM on tissue remodeling after transplantation is further discussed.
Results
Ocular Surface Wound Healing after AM Transplantation
Cryopreserved iAM showed subtransparent apparance after mounted on culture insert (Fig. 1A). Devitalized AM epithelial cells were well maintained under phase contrast whole-mount observation (Fig. 1B), which was confirmed by H&E staining (Fig. 1C) and DAPI staining (Fig. 1D). After 0.02% EDTA treatment and electric toothbrush scraping, the transparency of AM increased (Fig. 1E), which had few epithelial cells on the AM surface under phase contrast microscopic observation (Fig. 1F), H&E staining (Fig. 1G) and DAPI staining (Fig. 1H) further confirmed the absence of epithelial cell on the dAM surface and an intact stroma. Immunostaining of collagen IV (Fig. 1I,L), collagen VII (Fig. 1J,M) and Laminin 5 (Fig. 1K,N) showed all these basement membrane components were well preserved after amniotic membrane epithelial denudation.
After the microscopic evaluation, the iAM and dAM were used for rabbit ocular surface reconstruction surgery. Two days after AM transplantation on rabbit limbal area, both iAM and dAM attached well, and there was no hemorrhage or injection under the AM (Fig. 2D). Five days after the surgery, neovascularization was observed underneath the AM that originated from the limbal area, the border between transplanted AM and the host conjunctiva was clear (Figs 1W and 2). Two weeks postsurgery, both iAM and dAM were vascularized, the density of blood vessel showed no dramatic difference between AM and surrounding ocular surface tissue, the border between transplanted AM and the host conjunctiva was not clear (Fig. 2W). Three weeks post surgery, mild increase in the thickness of the conjunctival tissue and rough surface at the iAM transplantation loci was observed. The new blood vessels underneath the conjunctival tissue were not clearly demonstrated under the slit-lamp microscope. In contrast, dAM transplanted area did not show conjunctival thickening, the conjunctival surface was smooth, and the blood vessels underneath the conjunctival were clearly showed (Figs 2 and 3W).
Fluorescein staining was performed to determine the epithelization of the AM surface. Two days post surgery, majority of the iAM surface was stained with fluorescence dye, however, fluorescence stained area was remarkably smaller on dAM surface. Spotted patterns of positive fluorescene staining persisted even after two weeks on iAM while it was negative on dAM (Fig. 3A). Statistic analysis showed that the area of epithelization on dAM was larger than that of iAM at day 2 and day 3 (Fig. 3B), indicating the epithelial wound healing was rapid on dAM than on iAM.
Ocular Surface Tissue Remodeling after AM Transplantation
H&E staining of the rabbit corneal and conjunctival tissue after AM transplantation was performed to demonstrate the tissue remodeling after AM transplantation. The results showed that 2 weeks post surgery, well stratified epithelium was observed on the surface of the transplanted area in iAM (Fig. 4A) as well as dAM (Fig. 4B) group. The stromal cellularization of the iAM group was obviously higher than that of dAM group. Three weeks after the surgery, the epithelium on the surface of the transplanted area were uniform and smooth in iAM (Fig. 4C) and dAM group (Fig. 4D). Interestingly, we found a folded matrix like tissue in the stroma of the surgery area in iAM group (Fig. 4C), while dAM group showed homogenous stroma (Fig. 4D). To further confirm the process of tissue remodeling post iAM or dAM transplantation, we performed immunostaining using antibody that specifically recognize human type VII collagen, which is one of the major components of AM basement membrane. As predicted, one week post surgery, strong positive staining was obsereved on the surface of the surgery area in both groups (Fig. 5). Two weeks after the surgery, type VII collagen staining showed folded matrix like structure under the surface epithelium in iAM group, however, there was no positive staining in dAM group. At 3 weeks, type VII collagen staining was positive in deep stroma of the surgery area in iAM group, fitting the position of matrix like tissue observed in H&E staining (Fig. 4C), while there was no staining in dAM group (Fig. 5). These results indicated that when ocular surface was reconstructed with iAM, the AM do not degraded completely and the remnants were gradually embedded into deep stroma of the regenerated host tissue. However, if the ocular surface was reconstructed with dAM, AM degraded within 2 weeks.
Ocular Surface Epithelial Differentiation after AM Transplantation
We then performed keratin K12 and K19 immunostaining, and PAS staining to investigate the epithelial differentiation status after iAM or dAM transplantation. K12 represents terminal differentiation of corneal epithelial phenotype, K19 represents conjunctival epithelial phenotype, while PAS staining reveals goblet cell phenotype. Two weeks after the surgery, the stratified epithelium in the AM border of limbal area showed strong expression of K12, in both iAM (Fig. 6a) and dAM group (Fig. 6c), while on the surface of AM that covered surgery area, the K12 positive staining was observed only on the superficial layer of epithelial cells in both iAM (Fig. 6b) and dAM group (Fig. 6d), indicating the incomplete differentiation of epithelial cells on the surgery area. Similar pattern was observed at 3 weeks post-surgery (Fig. 6C,D). K19 was expressed on the conjunctival side of the transplantation area in both groups, and showed no significant difference between 2 weeks (Fig. 7A,B) and 3 weeks (Fig. 7C,D).
PAS staining showed the absence of goblet cell on day 2 on both iAM and dAM. PAS positive cells were observed on the conjunctival side of dAM one week post surgery and dramatically increased after 2 weeks. However, there was no PAS positive cells on iAM until 3 weeks. After 3 weeks, the number and pattern of goblet cells in dAM group were similar to that of the normal conjunctiva (Fig. 8).
Stromal Inflammation and Scar Formation after AM Transplantation
Macrophage play the leading role during the intermediate and late stages of inflammation during wound healing. We investigated macrophage infiltration after the AM transplantation using macrophage specific antibody. Macrophages were observed in the stroma of iAM transplantation loci at 1 week and dramatically increased at 2 weeks, and dispersed throughout the stroma at 3 weeks (Fig. 9A). However, macrophage were absent in the dAM transplantation loci 1 week post surgery, a few macrophages emerged in the stroma 2 weeks after the surgery, and their numbers slightly increased at 3 weeks (Fig. 9A). IOD analysis confirmed the significant difference in the rate of macrophage infiltration between the two groups at all time points (Fig. 9B).
To further investigate the wound healing after AM transplantation, we performed α-SMA immunostaining, marker of myofibroblast, that is present in the scared and fibrotic tissues. Two weeks after the surgery, α-SMA positive cells were presented in the deep stroma of the iAM transplantation loci, and the α-SMA expression became stronger and more condensed at 3 weeks. However, α-SMA positive cells were absent in the stroma of dAM transplantation loci at 2 weeks and 3 weeks other than blood vessel staining (Fig. 10). These data indicated that there was no scar formation and fibrosis after dAM transplantation.
Discussion
This study compared the efficacy of iAM and dAM after in vivo transplantation on the basis of re-epithelialization and cell differentiation, inflammatory response, dissolution of basement membrane, fibrosis and scar formation. We found dramatic difference of tissue remodeling pattern after ocular surface reconstruction with iAM or dAM.
Firstly, the re-epithelialization of dAM after transplantation is rapid than that of iAM. Complete re-epithelialization was achieved within one week on transplanting dAM measuring 5 × 5 mm in rabbit. This was in consistence with ex vivo limbal explant culture, whereby outgrowth was hastened on dAM47,52. In dAM transplantation group, the basement membrane is directly exposed to the migrating epithelial cells. Previous study has shown that basement membrane of AM acts as a substrate supporting adhesion, growth, and differentiation of epithelial basal progenitor cells, facilitating migration of epithelial cells53. Studies have also demonstrated that in ex vivo limbal explant culture, the devitalized AM epithelial cells on iAM were disintegrated by matrix metalloproteinase produced by migrating epithelial cells and are removed during the process of epithelial cell expansion47. This procedure may hinder the migration rate of the epithelium. We presume that re-epithelialization of iAM after in vivo transplantation may follow similar machinery.
Basement membrane is important extracellular matrix which can facilitate epithelial cell attachment and migration. We found basement membrane components such as collagen IV, collagen VII and laminin 5 were well preserved on dAM after epithelium denudation. Our previous study proved that during ex vivo limbal explant culture on AM, the basement membrane components of AM dissolved within one week regardless of iAM and dAM47. In the current in vivo transplantation study, we found that type VII collagen, one of the major basement membrane components, was completely degraded at 2 weeks in dAM, whereas remained intact in iAM after 3 weeks. Therefore, in vivo dissolution of basement membrane components is delayed and there is difference between iAM and dAM. Our results also suggested that the basement membrane components of AM only act as temporary carrier or scaffold for epithelial migration, epithelial cells grown on AM eventually are capable of synthesizing and establishing their basement membrane.
Tissue remodeling procedure after tissue transplantation is critical to regain normal structure and physiological function54. Two weeks after AM transplantation, the graft loci became smooth in both groups. Based on the H&E staining results, we recognized that iAM was embedded into deep stroma of transplantation loci 3 weeks post surgery. This was also confirmed by type VII collagen staining. Such an integration of AM with the recipient tissue maybe beneficial if the purpose of the AM transplantation is for the conjunctival or fornix reconstruction. The embedded AM can act as tenon capsule or subconjunctival connective tissue. This concept has been applied in the treatment of conjunctivochalasis using AM to reinforce the strength of conjunctiva55. However, in the dAM transplantation group, we did not notice the remnant of dAM in the graft loci, and the cellularity of the graft loci stroma was quite homogeneous. Therefore, we presume that dAM was completely integrated into the host tissue, or it was completely degraded within 2 weeks. Contradictory conclusions are available in literature stating that transplanted AM survived and integrated into the host corneal tissue being modified or remodeled by the recipient cells56, while another study showed absence of AM remnants in recipient ocular surface months after AM transplantation in various diseases24.
The main purpose of AM transplantation for ocular surface reconstruction is to regenerate healthy epithelium. In rabbit models, we generated limbal stem cell deficiency and conjunctival defective rabbit model by partial limbal tissue and conjunctival tissue removal. We found that corneal epithelial differentiation was similar on iAM and dAM. It is generally accepted that epithelial cells expanded on iAM maintain more progenitor characteristic than that on dAM42,47,48. In other words, dAM promote differentiation of the epithelial cells. However, our in vivo data found that there was no dramatic difference of epithelial cell phenotype after transplantation of iAM or dAM. A major difference observed in our study is the presence of goblet cells on dAM 2 weeks after transplantation, indicating dAM may facilitate goblet cell differentiation.
Another intriguing finding of current study is that there was decreased macrophage infiltration in dAM group compared to iAM group, indicating dampened inflammatory response after dAM transplantation. As we know, re-epithelialization is the key procedure of epithelial wound healing. Inflammation tampers only after complete of epithelialization. Therefore, rapid re-epihtelialization in dAM group may be beneficial in reducing inflammation, that resulted in decreased macrophage infiltration. Another possibility of higher infiltration of macrophages in iAM may be due to the presence of devitalized AM epithelial cells. Disintegration of these cells may attract macrophages at the transplantation site to perform the function of dead cell scavenging. The embedded human AM tissue are capable of directly recruiting macrophages as they are rich source of human xeno-proteins. On considering the consequence of the xenoproteins, dAM may be the better choice in terms of reducing local inflammation.
Another supportive evidence is that after iAM transplantation, increased number of α-SMA positive cells accumulated in the stroma at the surgery loci. Since we can easily dissociate α-SMA positive blood vessels, the α-SMA positive cells should be the myofibroblasts, which are observed mainly in scar tissue. The macrophage can directly recruit myofibroblasts or through the secretion of inflammatory cytokines such as TGF-β that induces the transdifferentiation of fibroblast to myofibroblast57. Further investigation is required to prove whether the myofibroblasts originate from the blood circulation. We proposed that rapid re-epithelialization and degradation of AM tissue after wound healing may play critical role in the tissue remodeling after ocular surface reconstruction with dAM.
This study was performed in the ocular surface of healthy rabbits to investigate the ocular surface reconstruction procedure after AM transplantation. More intensive study should be conducted to compare the difference between iAM and dAM on ocular surface reconstruction under different conditions such as chemical burn or symblepharon. Although epithelial migration and healing is promoted on dAM, meantime, degradation is also hastened in dAM. Therefore, in ocular surface reconstruction of large defective area with obvious ocular surface inflammation, we do not recommend the use of dAM, as they degrade rapidly before complete epithelial healing that may lead to failure of the surgery. Future study is mandatory to address this query in animal model and clinical setting. Long term observation after surgery is also required to observe the outcome of the ocular surface reconstruction. Additionally, investigations to explain the mechanism of action behind the physiological properties of dAM continues to be of great interest according to our results.
In summary, our study for the first time conducted an in vivo study on the application of dAM on ocular surface reconstruction. Denudation of devitalized amniotic membrane epithelial cells facilitates epithelial repopulation and goblet cell differentiation, while further reduces inflammation and scar formation after transplantation. Our study may shed new light on the modification of amniotic membrane regarding its future application in clinic, dAM transplant could be a concomitant medical therapy in treating various ocular surface reconstructions.
Materials and Methods
Materials and Reagents
EDTA, Glycerin, 4′,6-diamidino-2-phenylindole I (DAPI), bovine serum albumin (BSA), mouse anti-type IV collagen antibody, mouse anti-human collagen VII antibody, and PAS kit were from Sigma (St. Louis, MO, US). Dulbecco’s modified Eagle medium (DMEM) without phenol red was from Invitrogen (Eugene, OR, US). Mouse anti-laminin 5 antibody, anti-cytokeratin 12 (K12) antibody, anti-cytokeratin 19 (K19) antibody, anti-vimentin antibody, anti-α smooth muscle actin (α-SMA) antibody, and mouse anti-macrophage monoclonal antibody were from Abcam (Cambridge, MA, US). FITC-conjugated anti–mouse IgG was from DAKO (Denmark).
Preparation of Denuded Amniotic Membrane
With informed consent, in accordance with the tenets of the Declaration of Helsinki for research involving human subjects, and with the approval from the institutional review board of Medical College of Xiamen University, human AM was obtained at the time of cesarean section from a healthy human placenta, and prepared as per our previous report58. Immediately before use, AM was thawed, washed thrice with sterile PBS, and cut into pieces approximately 20 × 20 mm in size. For preparation of dAM, membranes were deprived of their devitalized amniotic epithelial cells by incubation with 0.02% EDTA at 37 °C for 1 hour, to loosen the cellular adhesion, followed by gentle scraping with a cell electric toothbrush, cut into 5 × 5 mm pieces and used for transplantation47.
AM Transplantation and Post-operative Observation of Rabbits
Twenty four New Zealand white rabbits were obtained from Experimental Animal Center of Xiamen University, they were maintained and treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and according to an experimental procedure approved by the Committee for Animal Research at Xiamen University. The animals were anesthesized with pentobarbital at the dosage of 50 mg/kg intraperitonealy partial limbal and conjunctival tissue removal (5 × 5 mm in size) was performed in the upper limbal region of the both eyes. The identical size of human dAM and iAM were transplanted to the corresponding limbal and conjunctival area of the left and right eye, respectively. The transplanted eyes were observed under slit-lamp microscope, and the fluorescein staining was performed everyday for one week post-operatively, and once a week thereafter until three weeks. Ocular surface and fluorescein staining images were taken under slit lamp microscope. At the time points of 2 days, 4 days, 5 days, 1 week, 2 weeks, and 3 weeks, four rabbits were sacrificed, the transplanted area including peripheral cornea, limbus, conjunctival, and underneath sclera were removed and embedded in optimal cutting temperature (OCT) compound for cryosectioning.
Histology and Immunostaining
Cryostat sections (5 μm) of the rabbit tissues were fixed in acetone for 10 minutes at −20 °C. The sections used for immunostaining were rehydrated in PBS and then incubated in 0.2% Triton X-100 for 10 minutes. After three rinses with PBS for 5 minutes each and pre-incubation with 2% BSA to block nonspecific staining for 1 hour, the sections were incubated with primary antibodies (anti type VII collagen antibody at 1:400, others at 1:100) overnight at 4 °C. After three washes with PBS for 15 minutes, sections were incubated with an FITC-conjugated secondary antibody (chicken anti-mouse IgG at 1:100) for 45 minutes. After three additional PBS washes for 15 minutes, they were counterstained with DAPI (1:2000) for 1 minute, mounted in mounting medium and examined with a Nikon microscope (Nikon, Japan).
Periodic Acid-Schiff (PAS) Staining
Cryostat sections (5 μm) of the rabbit tissues were fixed in 95% alcohol for 30 minutes at room temperature. After three rinses with double distilled water (DDW) for 5 minutes each, the sections were treated with 1% periodic acid for 8 minutes. After additional three rinses with DDW, the sections were stained with Schiff reagent for 5 minutes and suspended with DDW until purple appear in evidence. The sections were then counter-stained with hematoxylin for 2 minutes, cleared in xylene, covered with mounting medium and observed under light microscope.
Statistical Analysis
Ocular surface fluorescein staining images representing epithelial healing process was analyzed using Image Pro Plus V6.0 (Media Cybernetics, Silver Spring, MD, USA) to calculate the relative surface area. Integrated optical density (IOD) of positive immuno-staining of anti-macrophage polyclonal antibody were also analyzed by Image Pro Plus V6.0 as previously reported59. Summary of the data were reported as mean ± SD. Group means were compared using the appropriate version of Student’s unpaired t-test, where p < 0.05 was considered statistically significant.
References
Danforth, D. & Hull, R. W. The microscopic anatomy of the fetal membranes with particular reference to the detailed structure of the amnion. Am J Obstet Gynecol 75, 536–547; discussion 548–550 (1958).
Tseng, S. C. et al. How does amniotic membrane work? Ocul Surf 2, 177–187 (2004).
Sorsby, A. & Symons, H. M. Amniotic membrane grafts in caustic burns of the eye (burns of the second degree). Br J Ophthalmol 30, 337–345 (1946).
Sorsby, A., Haythorne, J. & Reed, H. Further experience with amniotic membrane grafts in caustic burns of the eye. Br J Ophthalmol 31, 409–418 (1947).
Kim, J. C. & Tseng, S. C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14, 473–484 (1995).
Sabater, A. L. & Perez, V. L. Amniotic membrane use for management of corneal limbal stem cell deficiency. Curr Opin Ophthalmol 28, 363–369, https://doi.org/10.1097/ICU.0000000000000386 (2017).
Sheha, H., Liang, L., Li, J. & Tseng, S. C. Sutureless amniotic membrane transplantation for severe bacterial keratitis. Cornea 28, 1118–1123, https://doi.org/10.1097/ICO.0b013e3181a2abad (2009).
Kim, J. S., Kim, J. C., Na, B. K., Jeong, J. M. & Song, C. Y. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res 70, 329–337 (2000).
Meller, D. et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107, 980–989; discussion 990 (2000).
Sridhar, M. S., Bansal, A. K., Sangwan, V. S. & Rao, G. N. Amniotic membrane transplantation in acute chemical and thermal injury. Am J Ophthalmol 130, 134–137 (2000).
Kobayashi, A. et al. Temporary amniotic membrane patching for acute chemical burns. Eye (Lond) 17, 149–158 (2003).
Pan, D. P., Li, X. X. & Xu, J. F. Therapeutic effect of amniotic membrane transplantation for ocular burn. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 17, 318–320 (2003).
John, T., Foulks, G. N., John, M. E., Cheng, K. & Hu, D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109, 351–360 (2002).
Di Pascuale, M. A. et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112, 904–912 (2005).
Kruse, F. E., Rohrschneider, K. & Volcker, H. E. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology 106, 1504–1510; discussion 1511 (1999).
Hanada, K., Shimazaki, J., Shimmura, S. & Tsubota, K. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. Am J Ophthalmol 131, 324–331 (2001).
Rodriguez-Ares, M. T., Tourino, R., Lopez-Valladares, M. J. & Gude, F. Multilayer amniotic membrane transplantation in the treatment of corneal perforations. Cornea 23, 577–583 (2004).
Hick, S. et al. Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24, 369–377 (2005).
Pires, R. T. et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol 117, 1291–1297 (1999).
Mrukwa-Kominek, E., Gierek-Ciaciura, S., Rokita-Wala, I. & Szymkowiak, M. Use of amniotic membrane transplantation for treating bullous keratopathy. Klin Oczna 104, 41–46 (2002).
Mejia, L. F., Santamaria, J. P. & Acosta, C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea 21, 342–345 (2002).
Espana, E. M. et al. Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential. J Cataract Refract Surg 29, 279–284 (2003).
Anderson, D. F., Prabhasawat, P., Alfonso, E. & Tseng, S. C. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea 20, 354–361 (2001).
Tosi, G. M. et al. Amniotic membrane graft: histopathological findings in five cases. J Cell Physiol 202, 852–857 (2005).
Gomes, J. A. et al. Amniotic membrane transplantation for partial and total limbal stem cell deficiency secondary to chemical burn. Ophthalmology 110, 466–473 (2003).
Barabino, S. et al. Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 110, 474–480, https://doi.org/10.1016/S0161-6420(02)01892-4 (2003).
Solomon, A., Espana, E. M. & Tseng, S. C. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110, 93–100 (2003).
Honavar, S. G., Bansal, A. K., Sangwan, V. S. & Rao, G. N. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 107, 975–979 (2000).
Dua, H. S., Gomes, J. A., King, A. J. & Maharajan, V. S. The amniotic membrane in ophthalmology. Surv Ophthalmol 49, 51–77 (2004).
Park, W. C. & Tseng, S. C. Modulation of acute inflammation and keratocyte death by suturing, blood, and amniotic membrane in PRK. Invest Ophthalmol Vis Sci 41, 2906–2914 (2000).
Shimmura, S., Shimazaki, J., Ohashi, Y. & Tsubota, K. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20, 408–413 (2001).
Solomon, A. et al. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 85, 444–449 (2001).
Choi, T. H. & Tseng, S. C. In vivo and in vitro demonstration of epithelial cell-induced myofibroblast differentiation of keratocytes and an inhibitory effect by amniotic membrane. Cornea 20, 197–204 (2001).
Tseng, S. C., Li, D. Q. & Ma, X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 179, 325–335 (1999).
Kim, J. C. & Tseng, S. C. The effects on inhibition of corneal neovascularization after human amniotic membrane transplantation in severely damaged rabbit corneas. Korean J Ophthalmol 9, 32–46 (1995).
Grueterich, M., Espana, E. M., Touhami, A., Ti, S. E. & Tseng, S. C. Phenotypic study of a case with successful transplantation of ex vivo expanded human limbal epithelium for unilateral total limbal stem cell deficiency. Ophthalmology 109, 1547–1552 (2002).
Shimazaki, J. et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 109, 1285–1290 (2002).
Ricardo, J. R. et al. Transplantation of conjunctival epithelial cells cultivated ex vivo in patients with total limbal stem cell deficiency. Cornea 32, 221–228, https://doi.org/10.1097/ICO.0b013e31825034be (2013).
Ono, K. et al. Autologous transplantation of conjunctival epithelial cells cultured on amniotic membrane in a rabbit model. Molecular vision 13, 1138–1143 (2007).
Nakamura, T. et al. The successful culture and autologous transplantation of rabbit oral mucosal epithelial cells on amniotic membrane. Invest Ophthalmol Vis Sci 44, 106–116 (2003).
Sen, S. et al. Molecular characterization of explant cultured human oral mucosal epithelial cells. Invest Ophthalmol Vis Sci 52, 9548–9554, https://doi.org/10.1167/iovs.11-7946 (2011).
Koizumi, N. et al. Comparison of intact and denuded amniotic membrane as a substrate for cell-suspension culture of human limbal epithelial cells. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 245, 123–134, https://doi.org/10.1007/s00417-005-0095-3 (2007).
Krishnan, S., Sudha, B. & Krishnakumar, S. Isoforms of p63 in corneal stem cells cultured on human amniotic membrane. Biologicals: journal of the International Association of Biological Standardization 38, 570–576, https://doi.org/10.1016/j.biologicals.2010.05.004 (2010).
Sudha, B., Sitalakshmi, G., Iyer, G. K. & Krishnakumar, S. Putative stem cell markers in limbal epithelial cells cultured on intact & denuded human amniotic membrane. The Indian journal of medical research 128, 149–156 (2008).
Sudha, B., Jasty, S., Krishnan, S. & Krishnakumar, S. Signal transduction pathway involved in the ex vivo expansion of limbal epithelial cells cultured on various substrates. The Indian journal of medical research 129, 382–389 (2009).
Raeder, S., Utheim, T. P., Messelt, E. & Lyberg, T. The impact of de-epithelialization of the amniotic membrane matrix on morphology of cultured human limbal epithelial cells subject to eye bank storage. Cornea 29, 439–445, https://doi.org/10.1097/ICO.0b013e3181ba0c94 (2010).
Li, W. et al. Basement membrane dissolution and reassembly by limbal corneal epithelial cells expanded on amniotic membrane. Invest Ophthalmol Vis Sci 47, 2381–2389 (2006).
Grueterich, M., Espana, E. & Tseng, S. C. Connexin 43 expression and proliferation of human limbal epithelium on intact and denuded amniotic membrane. Invest Ophthalmol Vis Sci 43, 63–71 (2002).
Westekemper, H. et al. Clinical outcomes of amniotic membrane transplantation in the management of acute ocular chemical injury. Br J Ophthalmol 101, 103–107, https://doi.org/10.1136/bjophthalmol-2015-308037 (2017).
Kohanim, S. et al. Acute and Chronic Ophthalmic Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis - A Comprehensive Review and Guide to Therapy. II. Ophthalmic Disease. Ocul Surf 14, 168–188, https://doi.org/10.1016/j.jtos.2016.02.001 (2016).
Sangwan, V. S., Matalia, H. P., Vemuganti, G. K. & Rao, G. N. Amniotic membrane transplantation for reconstruction of corneal epithelial surface in cases of partial limbal stem cell deficiency. Indian journal of ophthalmology 52, 281–285 (2004).
Koizumi, N. et al. Cultivation of corneal epithelial cells on intact and denuded human amniotic membrane. Invest Ophthalmol Vis Sci 41, 2506–2513 (2000).
Yeh, L. K. et al. Soluble lumican glycoprotein purified from human amniotic membrane promotes corneal epithelial wound healing. Invest Ophthalmol Vis Sci 46, 479–486 (2005).
Weber, B. et al. Tissue engineering on matrix: future of autologous tissue replacement. Seminars in immunopathology 33, 307–315, https://doi.org/10.1007/s00281-011-0258-8 (2011).
Kheirkhah, A. et al. Amniotic membrane transplantation with fibrin glue for conjunctivochalasis. Am J Ophthalmol 144, 311–313, https://doi.org/10.1016/j.ajo.2007.03.044 (2007).
Stoiber, J., Muss, W. H., Pohla-Gubo, G., Ruckhofer, J. & Grabner, G. Histopathology of human corneas after amniotic membrane and limbal stem cell transplantation for severe chemical burn. Cornea 21, 482–489 (2002).
Hartupee, J. & Mann, D. L. Role of inflammatory cells in fibroblast activation. Journal of molecular and cellular cardiology 93, 143–148, https://doi.org/10.1016/j.yjmcc.2015.11.016 (2016).
Tan, Y. et al. Amniotic membrane inhibits squamous metaplasia of human conjunctival epithelium. Am J Physiol Cell Physiol 301, C115–125 (2011).
Dong, N. et al. Abnormal epithelial differentiation and tear film alteration in pinguecula. Invest Ophthalmol Vis Sci 50, 2710–2715, https://doi.org/10.1167/iovs.08-2905 (2009).
Acknowledgements
This study was supported in part by the grants from Chinese National Key Scientific Research Project (No. 2013CB967003 [to WL]), the National Natural Science Foundation of China (NSFC, No. 81770894, No. 81470602 [to WL], and No. 81330022 [to ZL]), the Fundamental Research Funds for the Central Universities of China (No. 2012121049, and No. 20720150171 [to WL]). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Jing Jie and Wei Li designed the experiments. Jing Jie, Jie Yang, Hui He, Liying zhang, Zhiyuan Li and Jingyao Chen conducted the experiments. Zuguo Liu, Jianlan Zheng, Wenyan Wang, Nuo Dong and Huping Wu provided experimental materials. Jing Jie, Wei Li, and Vimalin Jeyalatha M interpreted the data and wrote the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jie, J., Yang, J., He, H. et al. Tissue remodeling after ocular surface reconstruction with denuded amniotic membrane. Sci Rep 8, 6400 (2018). https://doi.org/10.1038/s41598-018-24694-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-24694-4
- Springer Nature Limited
This article is cited by
-
Construction of living-cell tissue engineered amniotic membrane for ocular surface disease
BMC Ophthalmology (2024)
-
Cryopreservation of human amniotic membrane for ocular surface reconstruction: a comparison between protocols
Cell and Tissue Banking (2022)
-
Fabrication of Decellularized Amnion and Chorion Scaffolds to Develop Bioengineered Cell-Laden Constructs
Cellular and Molecular Bioengineering (2022)
-
Cellular therapy of corneal epithelial defect by adipose mesenchymal stem cell-derived epithelial progenitors
Stem Cell Research & Therapy (2020)
-
Burn and Wound Healing Using Radiation Sterilized Human Amniotic Membrane and Centella asiatica Derived Gel: a Review
Regenerative Engineering and Translational Medicine (2020)